3-111884729-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001134438.2(PHLDB2):c.652G>T(p.Ala218Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000347 in 1,613,954 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001134438.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PHLDB2 | NM_001134438.2 | c.652G>T | p.Ala218Ser | missense_variant | Exon 2 of 18 | ENST00000431670.7 | NP_001127910.1 | |
PHLDB2 | NM_001134439.2 | c.652G>T | p.Ala218Ser | missense_variant | Exon 2 of 18 | NP_001127911.1 | ||
PHLDB2 | NM_001134437.2 | c.733G>T | p.Ala245Ser | missense_variant | Exon 3 of 18 | NP_001127909.1 | ||
PHLDB2 | NM_145753.2 | c.652G>T | p.Ala218Ser | missense_variant | Exon 2 of 17 | NP_665696.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152072Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250834Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135548
GnomAD4 exome AF: 0.0000328 AC: 48AN: 1461882Hom.: 0 Cov.: 33 AF XY: 0.0000385 AC XY: 28AN XY: 727238
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152072Hom.: 0 Cov.: 32 AF XY: 0.0000808 AC XY: 6AN XY: 74272
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.652G>T (p.A218S) alteration is located in exon 2 (coding exon 1) of the PHLDB2 gene. This alteration results from a G to T substitution at nucleotide position 652, causing the alanine (A) at amino acid position 218 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at